Parallel Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.6K | Buy |
732
+669
| +1,062% | +$24.3K | ﹤0.01% | 2045 |
|
|
2025
Q1 | $2.28K | Sell |
63
-162
| -72% | -$5.87K | ﹤0.01% | 2925 |
|
|
2024
Q4 | $9.47K | Sell |
225
-294
| -57% | -$12.4K | ﹤0.01% | 2403 |
|
|
2024
Q3 | $28.8K | Buy |
519
+308
| +146% | +$17.1K | ﹤0.01% | 1872 |
|
|
2024
Q2 | $8.67K | Buy |
211
+143
| +210% | +$5.88K | ﹤0.01% | 2349 |
|
|
2024
Q1 | $3.18K | Buy |
68
+37
| +119% | +$1.73K | ﹤0.01% | 2671 |
|
|
2023
Q4 | $1.48K | Sell |
31
-238
| -88% | -$11.4K | ﹤0.01% | 2867 |
|
|
2023
Q3 | $9.59K | Sell |
269
-175
| -39% | -$6.24K | ﹤0.01% | 2227 |
|
|
2023
Q2 | $20.5K | Buy |
444
+303
| +215% | +$14K | ﹤0.01% | 1838 |
|
|
2023
Q1 | $5.65K | Sell |
141
-194
| -58% | -$7.78K | ﹤0.01% | 2365 |
|
|
2022
Q4 | $15.5K | Buy |
335
+221
| +194% | +$10.2K | ﹤0.01% | 1829 |
|
|
2022
Q3 | $5K | Buy |
114
+17
| +18% | +$746 | ﹤0.01% | 2291 |
|
|
2022
Q2 | $6K | Buy |
97
+42
| +76% | +$2.6K | ﹤0.01% | 2187 |
|
|
2022
Q1 | $4K | Sell |
55
-34
| -38% | -$2.47K | ﹤0.01% | 2385 |
|
|
2021
Q4 | $7K | Buy |
89
+84
| +1,680% | +$6.61K | ﹤0.01% | 2261 |
|
|
2021
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 3199 |
|
|
2021
Q2 | – | Sell |
-7
| Closed | -$1K | – | 3021 |
|
|
2021
Q1 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 2657 |
|
|
2019
Q3 | – | Sell |
-28
| Closed | -$2K | – | 2468 |
|
|
2019
Q2 | $2K | Hold |
28
| – | – | ﹤0.01% | 2099 |
|
|
2019
Q1 | $2K | Sell |
28
-270
| -91% | -$19.3K | ﹤0.01% | 2087 |
|
|
2018
Q4 | $12K | Buy |
298
+252
| +548% | +$10.1K | ﹤0.01% | 1252 |
|
|
2018
Q3 | $4K | Hold |
46
| – | – | ﹤0.01% | 1812 |
|
|
2018
Q2 | $3K | Hold |
46
| – | – | ﹤0.01% | 1759 |
|
|
2018
Q1 | $2K | Hold |
46
| – | – | ﹤0.01% | 1864 |
|
|
2017
Q4 | $2K | Buy |
+46
| New | +$2K | ﹤0.01% | 1873 |
|